Upcoming events on ROCHE HOLDING AG |
|
01/28/21 | | International Association for the Study of Lung Cancer World Conference |
02/04/21 | 07:00am | | Jahr 2020 Ergebnisveröffentlichung |
02/04/21 | 02:00pm | | Jahr 2020 Präsentation des Ergebnisses |
02/17/21 | | Citi Immuno-oncology Leadership Summit |
|
Past events on ROCHE HOLDING AG |
|
01/17/21 | 09:30pm | | American Society of Clinical Oncology Virtual Gastrointestinal Cancers Symposium |
01/14/21 | | Octavian Seminar |
01/11/21 | | JP Morgan Healthcare Conference |
12/24/20 | | Jefferies Global Healthcare Conference |
|
Upcoming sector events for ROCHE HOLDING AG |
|
|
|
Past sector events for ROCHE HOLDING AG |
|
|
|
Annual results | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 (e) |
Sales M CHF |
Released Forecast Spread | 48 145 47 916 0,48% | 50 576 50 686 -0,22% | 53 299 53 126 0,33% | 56 846 56 448 0,70% | 61 466 61 789 -0,52% | 59 276
|
Operating income (EBITDA) M CHF |
Released Forecast Spread | 19 558 19 548 0,05% | 20 483 20 420 0,31% | 21 201 20 725 2,3% | 22 825 22 398 1,9% | 25 419 24 199 5,0% | 24 525
|
Operating profit (EBIT) M CHF |
Released Forecast Spread | 17 542 17 340 1,2% | 18 420 18 651 -1,2% | 19 012 19 361 -1,8% | 20 505 20 431 0,36% | 22 479 22 680 -0,89% | 21 621
|
Pre-Tax Profit (EBT) M CHF |
Released Forecast Spread | 11 987 14 023 -15% | 13 007 14 865 -12% | 12 248 14 738 -17% | 14 148 17 012 -17% | 16 614 18 369 -9,6% | 18 289
|
Net income M CHF |
Released Forecast Spread | 8 863 10 434 -15% | 9 576 10 611 -9,8% | 8 633 10 674 -19% | 10 500 12 780 -18% | 13 497 14 257 -5,3% | 14 335
|
EPS CHF |
Released Forecast Spread | 10,3 12,1 -15% | 11,1 12,6 -12% | 10,0 12,5 -20% | 12,2 15,3 -20% | 15,6 16,6 -5,7% | 16,5
| Announcement Date | 01/28/2016 | 02/01/2017 | 02/01/2018 | 01/31/2019 | 01/30/2020 | |
|
|
Quarterly results | 2015 S2 | 2016 S1 | 2016 S2 | 2017 S1 | 2017 S2 | 2018 Q1 | 2018 Q2 | 2018 S1 | 2018 Q3 | 2018 Q4 | 2018 S2 | 2019 Q1 | 2019 Q2 | 2019 S1 | 2019 Q3 | 2019 Q4 | 2019 S2 | 2020 Q1 | 2020 Q2 | 2020 S1 | 2020 Q3 (e) | 2020 Q4 (e) | 2020 S2 (e) | 2021 Q1 (e) | 2021 Q2 (e) | 2021 Q3 (e) | 2021 S1 (e) | 2021 S2 (e) | 2022 S1 (e) | 2022 S2 (e) |
Sales M CHF |
Released Forecast Spread | 24 560 24 251 1,3% | 25 020 24 829 0,77% | 26 000 25 660 1,3% | 26 344 26 127 0,83% | 26 955 26 762 0,72% | 13 583 13 385 1,5% | 14 528 14 015 3,7% | 28 111 27 568 2,0% | 13 969 13 830 1,0% | 14 766 14 534 1,6% | 28 735 28 366 1,3% | 14 826 14 390 3,0% | 15 643 15 467 1,1% | 30 469 30 275 0,64% | 15 597 15 083 3,4% | 15 400 15 852 -2,8% | 30 997 31 426 -1,4% | 15 143 14 736 2,8% | 14 138 14 989 -5,7% | 29 281 30 369 -3,6% | 15 091
| 15 152
| 30 126
| 15 377
| 15 183
| 15 648
| 29 457
| 32 008
| 31 575
| 33 135
|
Operating income (EBITDA) M CHF |
Released Forecast Spread | 9 390 8 237 14% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating profit (EBIT) M CHF |
Released Forecast Spread | 8 306 8 281 0,30% | 9 850 9 608 2,5% | 8 570 8 714 -1,7% | 10 135 9 914 2,2% | 8 877 9 153 -3,0% |
|
| 11 162 10 480 6,5% |
|
| 9 343 9 269 0,80% |
|
| 12 363 11 862 4,2% |
|
| 10 116 10 525 -3,9% |
|
| 11 766 11 824 -0,49% |
|
| 9 893
|
|
|
|
|
|
|
|
Pre-Tax Profit (EBT) M CHF |
Released Forecast Spread | 4 907 6 783 -28% |
|
|
|
|
|
|
|
|
| 4 654 8 143 -43% |
|
| 10 354 11 145 -7,1% |
|
| 6 260 9 758 -36% |
|
| 10 181 10 632 -4,2% |
|
| 9 124
|
|
|
|
|
|
|
|
Net income M CHF |
Released Forecast Spread | 3 709 5 176 -28% | 5 378 6 022 -11% |
| 5 477 6 764 -19% |
|
|
|
|
|
| 3 191 6 551 -51% |
|
| 8 619 8 910 -3,3% |
|
| 4 878 6 896 -29% |
|
| 8 079 8 713 -7,3% |
|
| 7 084
|
|
|
|
|
|
|
|
EPS
|
Released Forecast Spread | 4,30 6,16 -30% | 6,24 7,28 -14% | 4,89 6,40 -24% | 6,37 7,06 -9,7% | 3,67 6,38 -42% |
|
| 8,51 8,26 3,0% |
|
| 3,70 7,29 -49% |
|
| 9,99 9,66 3,4% |
|
| 5,63 7,56 -26% |
|
| 9,32 9,70 -3,9% |
|
| 8,24
|
|
|
|
|
|
|
| Announcement Date | 01/28/2016 | 07/21/2016 | 02/01/2017 | 07/27/2017 | 02/01/2018 | 04/26/2018 | 07/26/2018 | 07/26/2018 | 10/17/2018 | 01/31/2019 | 01/31/2019 | 04/17/2019 | 07/25/2019 | 07/25/2019 | 10/16/2019 | 01/30/2020 | 01/30/2020 | 04/22/2020 | 07/23/2020 | 07/23/2020 | | | | | | | | | | |
|
Financial data source © 2021 S&P Global Market Intelligence
|
|
© 2021 Factset
|
|
|
|
AstraZeneca shares fall on 'hefty' $39-billion Alexion deal |
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|